Dec. 5 at 9:29 AM
WATCHLIST DEC 05 2024.
$ATHE Alterity Therapeutics shares are trading higher after the company announced its last patient for the ATH434-201 Phase 2 trial has completed the study with topline results expected in early 2025.
$BLUE Bluebird Bio shares are trading higher after the company announced it joined the CMMI cell and gene therapy access model and will offer outcomes-based agreements to expand Medicaid access to LYFGENIA gene therapy for sickle cell disease.
$NFBK Keefe, Bruyette & Woods Maintains Market Perform on Northfield Bancorp, Raises Price Target to
$14.25
$ALT Pure Storage Posts Upbeat Results, Joins Cross Country Healthcare, Marvell Technology, Stoke Therapeutics And Other Big Stocks Moving Higher On Wednesday
$PLD Scotiabank Maintains Sector Outperform on Prologis, Lowers Price Target to
$134